However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

Pharmexcil announces business delegation to Zambia, Tanzania & DR Congo from March 24 to April 1: Shardul Nautiyal, Mumbai Wednesday, February 12, 2025, 08:00 Hrs [IST] The Pharma ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

India’s CDMO market has seen a record growth trajectory due to cost advantages, technological advancements, and strong ...

Draft Pharma Policy 2025 of Odisha encourages ease of doing businesses: Peethaambaran Kunnathoor, Chennai Wednesday, February 12, 2025, 08:00 Hrs [IST] Following the ‘Make-in-Od ...

Jonathan Hunt has stepped down as the managing director and CEO of Syngene International, with Peter Bains appointed as the ...

Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on “Pharma Innovations: Cross-Disciplinary Approaches in Drug Development and Healthcare” on Friday, ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

In the Indian stock market, FIIs are booking profits, domestic investors are treading carefully, and valuations are stretched ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...